BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 03/11/2017

FDA Clears REVEX Nalmefene Hydrochloride Injection for Approval

The US Food and Drug Administration has determined that REVEX, a nalmefene hydrochloride injection, was not withdrawn from sale due to safety or effectiveness concerns, paving the way for potential approval of abbreviated new drug applications.

Source: Federal Register — Food and Drug AdministrationOpen original release →